文献速递瓣膜外科

术前肌少症筛查可改善老年外科主动脉瓣置换术患者的风险预测

Benefit of Sarcopenia Screening in Older Patients Undergoing Surgical Aortic Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2021-07-29

这项回顾性单中心队列研究纳入874例≥65岁行外科主动脉瓣置换术患者,利用术前CT第3腰椎水平骨骼肌面积计算性别特异性Z评分,最低三分位定义为肌少症。结果显示肌少症与30天死亡率、30天院内事件及1年死亡率独立相关,且Z评分加入STS预测风险评分后可改善早期不良事件的预测能力(均P < .005)。

要点

  • 术前CT测量的肌少症与外科主动脉瓣置换术后早期不良事件和远期死亡独立相关。
  • 肌少症Z评分可在STS预测风险评分基础上改善早期不良事件的预测。
  • 对≥65岁外科主动脉瓣置换患者,术前CT肌少症筛查有助于风险再分层。

核心结论

  • 肌少症患者行外科主动脉瓣置换术后早期不良事件和远期死亡风险显著高于非肌少症患者。
  • 术前CT确定的肌少症可增强术后结局风险的预测能力。

研究设计与样本

  • 回顾性单中心队列研究,纳入874例2009至2016年间行外科主动脉瓣置换术且年龄≥65岁的患者。
  • 通过术前CT第3腰椎下缘水平基于机器学习分析测量总骨骼肌面积,以身高平方(cm2/m2)计算,并计算性别特异性Z评分,最低Z评分三分位定义为肌少症。

主要发现

  • 30天死亡率为4.7%,30天院内事件率为17.6%,1年死亡率为8.0%。
  • 随着Z评分降低,早期不良事件的比值呈阶梯式增加。
  • 肌少症与更高的30天死亡率、30天院内事件及1年死亡率独立相关。
  • 重分类分析显示,在STS预测死亡风险评分基础上加入Z评分后,对早期不良事件的预测能力改善(均P < .005)。

临床怎么用

  • 对≥65岁拟行外科主动脉瓣置换术的患者,可考虑术前CT肌少症筛查以辅助风险分层。
  • 肌少症评估结果可与STS预测风险评分结合,用于识别早期不良事件高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia, known as physical frailty, is highly prevalent in older patients and is related to adverse outcomes after cardiac surgery. However whether sarcopenia assessment can reclassify an individual patient's risk, which is estimated by Society of Thoracic Surgeons-predicted risk of mortality scores in patients who undergo surgical aortic valve replacement, is unclear. METHODS: This retrospective, single-center, cohort study comprised 874 patients aged ≥65 years who underwent surgical aortic valve replacement between 2009 and 2016. Total skeletal muscle area was calculated using height squared (cm2/m2) and was measured by preoperative computed tomography at the third lumbar vertebra inferior border using machine learning-based analysis. Sex-specific Z-scores were calculated, and patients in the lowest Z-score tertile were considered to have sarcopenia. The primary endpoint was 30-day mortality, and secondary endpoints were in-hospital events, 1-year mortality, and long-term mortality. RESULTS: Thirty-day mortality, 30-day in-hospital events, and 1-year mortality rates were 4.7%, 17.6%, and 8.0%, respectively. As the Z-score decreased, the odds of an early adverse event showed a stepwise increase. Sarcopenia was independently associated with higher 30-day mortality, 30-day in-hospital events, and 1-year mortality. Reclassification analyses showed improvements in the ability to predict early adverse events after adding the Z-scores over and above The Society of Thoracic Surgeons-predicted risk of mortality scores (all P < .005). CONCLUSIONS: Sarcopenic patients had significantly higher risks of early adverse events and long-term mortality after undergoing surgical aortic valve replacement than nonsarcopenic patients. Sarcopenia determined by preoperative computed tomography can enhance the prediction of postoperative outcome risk.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lee SA, Jang IY, Park SY, et al. Benefit of Sarcopenia Screening in Older Patients Undergoing Surgical Aortic Valve Replacement. Ann Thorac Surg. 2021. PMID: 34332995. doi:10.1016/j.athoracsur.2021.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。